ÃÛÌÒAPP

CLEVELAND - The healthcare industry, along with many others, is drowning in data. From electronic medical records to Medicaid data, the volume of information continues to grow and much of it is inaccessible. Today, the Ohio Department of Health and ÃÛÌÒAPP School of Medicine…

CLEVELAND - The three Clinical and Translational Science Award (CTSA) institutions in Ohio — ÃÛÌÒAPP, University of Cincinnati and The Ohio State University — and their partnering institutions have established a statewide collaborative agreement allowing a single…

ÃÛÌÒAPP researchers have taken a dramatic step forward in the fight against cancer—all by starting at the very beginning. Scientists led by School of Medicine Professor Mark W. Jackson set out to find a gene with the potential to turn healthy cells into cancerous ones. By…

CLEVELAND - A team of researchers at ÃÛÌÒAPP School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells. Using this method, the Jackson laboratory has identified a new…

ÃÛÌÒAPP’s ambitious collaboration to bring medical discoveries to patients has won an extraordinary endorsement: a $64.6 million federal grant that is the largest ever awarded in Northeast Ohio. “Five years ago Cleveland’s leading biomedical institutions came together in an…

Imagine curing cancer without nausea, hair loss, swelling or any of the other maladies that can accompany chemotherapy or radiation. This week researchers at ÃÛÌÒAPP School of Medicine took an extraordinary step toward realizing that remarkable vision. And, as so often…

Cleveland – The Ohio Third Frontier Commission unanimously awarded ÃÛÌÒAPP’s  National Center for Regenerative Medicine (NCRM), $2.4 million for its OH-Alive Innovator Platform: A Process and Manufacturing Platform for Cell Therapy.  These funds must be matched by NCRM and…

CLEVELAND - Nationally renowned researcher Mukesh K. Jain, MD, of ÃÛÌÒAPP School of Medicine has been elected to serve as vice president of the American Society for Clinical Investigation (ASCI). In the subsequent two years he will serve as president elect and ultimately…

CLEVELAND - A new study published in the July 11 issue of the Journal of Neurosciences details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America. Further, the research team from Case Western Reserve…

It is intuitive that most people would be less likely to take risks after an unexpected loss. But what happens after a surprising win? It turns out that the very same trend applies, according to ÃÛÌÒAPP psychologist Heath Demaree. In other words, it’s not whether you win or…